Immune checkpoint blockade induced shifts in cytokine expression patterns in peripheral blood of head and neck cancer patients are linked to outcome

BackgroundImmune-checkpoint blockade (ICB) of programmed-death-1 (PD-1) with pembrolizumab or nivolumab is approved for treating recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC). NadiHN and ADRISK are phase IIB trials investigating in locally advanced (LA) HNSCC having low or...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Louisa Röhl, Jana Wellhausen, Michael Berszin, Irene Krücken, Veit Zebralla, Markus Pirlich, Susanne Wiegand, Andreas Dietz, Theresa Wald, Gunnar Wichmann
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Frontiers Media S.A. 2023-10-01
Reeks:	Frontiers in Immunology
Onderwerpen:	immune checkpoint inhibitor-blockade (ICB) programmed-death 1 (PD-1) head and neck squamous cell carcinoma (HNSCC) liquid biopsy cytokine expression pattern (CEP) interferon gamma (IFN-γ)
Online toegang:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1237623/full
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!